Advertisement

Topics

Companies Related to "Altus Capital Partners" [Most Relevant Company Matches] - Page: 4 RSS

00:02 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Altus Capital Partners" found in our extensive corporate database of over 50,000 company records.

Showing "Altus Capital Partners" Companies 76–100 of 3,600+

Relevant

AXIOM VENTURE PARTNERS,L.P

Axiom Venture Partners provides capital and strategic assistance to rapidly growing high technology companies.Axiom’s professionals bring substantial investing experience and industry expertise to the venture capital process. With over $200M in capital under management, the firm seeks to consider investment proposals in two main industry areas.The first is High Technology which includes Communic...


Sofinnova Partners

1972 Sofinnova is the first venture capital company created in France.Sofinnova Partners is an independent venture capital company based in Paris. We have special relations with Sofinnova Ventures, our sister firm based in San Francisco. We invest primarily in companies in information technologies and life sciences, in France and in other European countries. A limited portion of our investments i...

Genesys Capital

With experience in building, managing and providing financing for high technology and biotechnology companies, Genesys Capital Partners has developed a strong business, professional and scientific network that provides practical insight into biotechnology-based opportunities. Genesys’ successful track record in venture investing, business development and life science research attracts high quali...


Moor Park Capital Partners

Moor Park Capital Partners, led by Gary Wilder, Shemeel Khan and Jagdeep Kapoor specialises in strategically driven, corporate finance led, real estate monetization transactions including sale and leaseback transactions for corporates, governments, financial institutions and municipalities with single tenants and multiple high quality assets in Western Eur...

Acurian, Inc.

Acurian is a leading full-service provider of clinical trial patient recruitment and retention solutions for the life sciences industry. Through its proprietary patient panel of more than 65 million patients, centralized advertising capabilities, and a fully hosted enrollment management technology platform, Acurian is able to identify, contact, prescreen, ...

AgTech Accelerator

AgTech Accelerator, established in 2016 in Research Triangle Park, is a venture development organization focused on discovering and developing emerging agricultural technology and animal health companies. Leveraging its single, highly engaged, shared management team, committed investors and academic institutional partners, AgTech Accelerator identifies, fo...

Durata Therapeutics, Inc.

Durata Therapeutics is a biopharmaceutical company addressing the growing need for new antibiotics to treat infectious diseases. Durata’s lead product candidate, dalbavancin, is in late-stage clinical development, and the Company also has two antibiotic programs in earlier-stage, preclinical research. Durata is supported by a premier team of venture c...

Vyome Biosciences

Vyome Biosciences (www.vyome.in) is a clinical stage dermatology based biopharmaceutical company, which has novel platforms technologies and a deep pipeline of novel drugs for antibiotic resistant Acne, other opportunistic pathogens and antifungal agents. Vyome has put-together a team of scientific and management experts from India and USA to deliver compa...

Greenfield Capital Partners

Greenfield Capital Partners is a Maryland based private equity fund that is a thought leader and value driver in the legal cannabis industry. Greenfield’s team has decades operational, direct investment and strategy formation experience that is unrivaled in the legal cannabis industry. Greenfield will use this experience along with its cannabis indust...

Forbion Capital Partners

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion’s investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investme...

Auriga Partners

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences. Enterprise creation represents the core activity of the Auriga's founding members since 1986. Our experienced management team of eight complements one another in education, experience, and sector specialization. Along with investin...

Arvelle Therapeutics

Arvelle Therapeutics is a biopharmaceutical company with the mission of bringing innovative solutions to patients suffering from CNS disorders. Arvelle is responsible for the development and commercialization of cenobamate, an investigational antiepileptic drug, in the European market. Arvelle is headquartered in Switzerland and received one of the largest...

Varagon Capital Partners

Varagon is a leading lender to middle market companies and private equity firms. Varagon invests across the capital structure and delivers flexible financing solutions that meet the needs of our private equity partners. Varagon provides investors with exposure to high-quality, directly-originated middle market loans through products designed for sophistica...

Great Hill Equity Partners IV, L.P. and certain of its affiliates

Great Hill Partners is an investment firm that manages over $2.7 billion in capital and focuses on investing in growth companies operating in the business and consumer services, media, transaction processing and software industries. Great Hill Equity Partners IV, L.P. and its affiliates target equity investments of $50 million to $150 million. For more information, please visit the Great Hill Part...

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focuses on making control or entrepreneur-driven investments. Since its formation in 1997, Irving Place Capital has been an investor in more than 50 companies and has raised over $4.0 ...

H.I.G. European Capital Partners Spain, S.L.U.

H.I.G. is a leading global private equity and alternative assets investment firm with €17.000 million of equity capital under management.* Based in Miami, and with offices in New York, Boston, Chicago, Dallas, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris and Rio de Janeiro,...

PBM Capital Group, LLC.

PBM Capital Group, LLC. is a private investment firm primarily focused on healthcare-related investments. Led by Paul Manning, a successful entrepreneur, PBM Capital partners with exceptional scientists, engineers and entrepreneurs who have developed game-changing technology that can improve and save the lives of millions of people. PBM has several inve...

Pritzker Group Private Capital

Pritzker Group, led by Tony and J.B. Pritzker, has three principal investment teams: Private Capital, which acquires and operates leading North America-based companies; Venture Capital, which is the largest technology venture investor based in the Midwest; and Asset Management, which partners with top-performing investment managers acrossÂ...

Flare Capital Partners

Flare Capital is a team of proven healthcare technology venture capital investors and senior operating executives known for their unparalleled strategic industry resources, insight and total commitment to the success of its entrepreneurs. Flare Capital raised one of the industry’s largest dedicated venture capital funds focused exclusively on early st...

Beam Therapeutics

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is bac...

Ancor Capital Partners

Ancor Capital Partners, based in Fort Worth, Texas, is an operations-oriented private equity firm focused on lower middle-market manufacturing and distribution companies with EBITDA of $5-$15 million. Extensive operational experience gives the Ancor team a unique understanding of the critical business issues faced by lower middle-market companies. Ancorâ...

Thomas, McNerney & Partners, LLC

Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in life science and medical technology companies at all stages of development. In addition to helping entrepreneurs launch companies with seed and early stage funding, the firm provides growth capital to emerging companies to advance clinical development or for p...

Nascent Pharmaceuticals, Inc.

Nascent Pharmaceuticals, Inc. is a privately held company funded by individual and institutional investors.Nascent’s lead institutional investor is Advantage Capital Partners, a private equity firm. Since 1992 Advantage has raised more than $700 million in institutional capital and has invested in a wide variety of companies and real estate projects. The firm targets its investment activities in...

ROTH Capital Partners, LLC

Roth Capital Partners, LLC (ROTH), is a relationship-driven full service investment bank focused on identifying opportunities for institutional investors in U.S.-listed equity securities of companies based in the U.S. and China. Headquartered in Newport Beach, CA, with offices throughout the U.S. and a Shanghai Representative Office, the employee-owned fir...

Westport Capital Partners LLC

Westport Capital Partners LLC provides domestic and international investment opportunities to institutional and private clients. Through its various funds, the firm invests in a wide variety of distressed and opportunistic real estate assets. The firm focuses on investments that have suffered from inadequate capitalization, mismanagement and poor leasing. ...


More From BioPortfolio on "Altus Capital Partners"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks